Skip to main content

You must have JavaScript enabled in order to access this part of the site. Please enable JavaScript and then reload this page in order to continue.

May 2026 TMPPM Update for Immunosuppressive Drugs

Last updated on

On May 1, 2026, the Texas Medicaid & Healthcare Partnership (TMHP) will update the “Immunosuppressive Drugs” section of the Texas Medicaid Provider Procedures Manual (TMPPM), Outpatient Drug Services Handbook to add Mycophenolate mofetil procedure code J7528.

Mycophenolate mofetil may be indicated for, but is not limited to, the prophylaxis of organ rejection in kidney, liver, and heart allogeneic transplants.

For more information, call the TMHP Contact Center at 800-925-9126 or the TMHP-CSHCN Services Program Contact Center at 800-568-2413.

Note: Texas Medicaid managed care organizations (MCOs) must provide all medically necessary, Medicaid-covered services to Medicaid members who are enrolled in their MCO. Administrative procedures, such as prior authorization, precertification, referrals, and claims and encounter data filing, may differ from traditional Medicaid (fee-for-service) and from MCO to MCO. Providers should contact the member’s specific MCO for details.